The global insulin pumps market was valued at USD 4.99 Billion in 2024, driven by the increased prevalence of obesity, and diabetes across the globe. The market is anticipated to grow at a CAGR of 6.20% during the forecast period 2025-2034 and reach a value of USD 9.11 Billion by 2034.
Base Year
Historical Year
Forecast Year
The increasing incidence of diabetes among people is contributing to the rising demand for insulin pumps, and insulin delivery systems, propelling market growth.
The market is witnessing innovative product launches to provide diabetic patients with technologically advanced products to manage their condition and improve patient outcomes.
The rising healthcare expenditure for diabetes treatment is poised to drive increased demand for diabetes management systems like insulin pumps and propel market value.
Value in USD Billion
2025-2034
Insulin Pumps Market Outlook
*this image is indicative*
Insulin is a hormone that is responsible for regulating blood glucose in the human body. Millions of people get affected by diabetes, in which the pancreas has difficulty producing enough insulin in the body. Insulin pumps are usually used to manage blood sugar levels in people who are suffering from diabetes.
The market growth can be attributed to the increasing incidence of diabetes globally. According to the International Diabetes Federation, 537 million people around the world are living with diabetes. The disease was responsible for 6.7 million deaths in 2021. The IDF further highlighted that diabetes caused a whopping USD 966 billion in health expenditure which is 316% more in comparison to the last 15 years.
Other factors boosting the market value include increased product launches and clearances from regulatory authorities like the FDA and EMA to bring advanced solutions to the patients. The emphasis on personalised care and integration of digital solutions into healthcare are amongst major market trends, expected to augment the demand for insulin pumps in the forecast period.
FDA Clearance Supporting Market Expansion
In June 2023, Beta Bionics, Inc., a medical technology company focused on diabetes received the United States FDA 510(k) clearance for Fiasp® Pumpcart® (insulin aspart) prefilled insulin cartridge. It is a first-of-its-kind automated insulin delivery system that completely automates all the user doses with three choices of insulin including Novolog®, Humalog® and Fiasp® Pumpcart®. The system has been developed to manage diabetes in patients without having to be supervised by a healthcare professional. The market is poised to be driven by product clearances by the FDA that enable effortless diabetes management.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Innovative Product Launches to Meet Rising Insulin Pumps Market Demand
In February 2024, Tandem Diabetes Care, Inc., a leader in insulin delivery and diabetes technology launched its new product Tandem Mobi. It is proposed to be the smallest, durable, automated insulin delivery system for diabetic patients. The product is a small wearable pump with Control-IQ technology that helps in predicting and preventing high and low blood sugar in patients. The insulin delivery system has several other impressive features poised to gain traction among people, propelling an increase in market demand. The market is expected to be driven by new product launches by key players, bringing innovation to the market and data-driven solutions to the patients.
The market is witnessing several trends and developments to improve the global current scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Technological Advancements | The market is influenced by continuous technological development such as smart insulin pumps with automated insulin delivery, integration with continuous glucose monitoring systems (CGM), and smartphone synchronisation for patient convenience and improving patient outcomes. |
| Rising Prevalence of Diabetes | The global diabetes burden is rising. This is leading to an increased demand for effective diabetes management solutions, including insulin pumps. The market value is also impacted by the evolving lifestyles of the population which includes unhealthy dietary habits, and lack of physical activity. |
| Digital Health Integration | The increasing integration of insulin pumps with digital health platforms and apps to enable data tracking, remote monitoring, and telemedicine is one of the significant market trends, driving market growth. |
| Preference for Personalised Care | The market is experiencing a rising trend toward personalisation in diabetes care. The companies are developing new features in insulin pumps such as customisable settings, with which a patient can manipulate the device to their needs and preferences. |
Market Breakup by Product Type:
Market Breakup by Indication:
Market Breakup by Distribution Channel
Market Breakup by Region:
Segmentation by Product Type Leads the Market Share
The market segmentation by product type includes insulin pumps and insulin pump supplies and accessories. Insulin pumps are further divided into tethered pumps and disposable/patch insulin pumps. Additionally, insulin pump supplies and accessories include insulin reservoirs/cartridges, and infusion set insertion devices. The market is expected to be dominated by the insulin pump supplies and accessories segment. The value for this segment is expected to be driven by the rising incidence of patients who require the products regularly.
Based on region, the market report offers insights into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the leading market due to the presence of global players in the region. The market dominance can be attributed to the factors like the increased prevalence of obesity, cost of treatment, technical innovations as well as product launches are also likely to drive regional growth. In addition, affluent companies are constantly undergoing merger and acquisition activities to boost their market presence and expand their product portfolio.
The key features of the market report comprise patent analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Insulet Corporation is an Acton, Massachusetts-based, American medical equipment manufacturing company focused on developing innovative products for diabetic patients and other conditions with its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods.
Headquartered in Dublin, Ireland, Medtronic is one of the largest medical device companies in the world. Their product portfolio covers various medical domains including cardiac and vascular devices, minimally invasive therapies, restorative therapies, and diabetes.
Also known as Roche, is a Swiss healthcare company focused on developing pharmaceuticals and diagnostics for the healthcare domain across the globe. Roche has an extensive portfolio dedicated to diabetic care with their Integrated Personalised Diabetes Management (iPDM) solutions. The major products by Roche used for glucose monitoring, insulin delivery, and other solutions to assist diabetic patients include Accu-Chek® and mySugr brands.
It is an American company focused on developing medical devices dedicated to assisting treatment procedures for diabetes specifically insulin infusion therapy. The company designs, develops, and commercialise products for diabetic patients using insulin. The innovative company portfolio includes t:slim X2™ insulin pump which now comes with Dexcom G5® mobile continuous glucose monitoring (CGM) integration. Another product includes t:flex® insulin pump, the first pump designed for people with greater insulin requirements.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Ypsomed AG
Based in Burgdorf, Switzerland, the company is a leader in developing and manufacturing infusion systems for self-medication. The company’s portfolio includes insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, and other diabetes supplies.
Other key players in the market include Ascensia Diabetes Care India Private Limited., Wuxi Apex Medical Co. Ltd., JingasuDelfu Co., Ltd., Sooil Development Co., Ltd, Valeritas, Inc., and A. Menarini Diagnostics S.r.l.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indication |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share